154 related articles for article (PubMed ID: 37877950)
1. Pre-transplant multidrug-resistant infections in liver transplant recipients-epidemiology and impact on transplantation outcome.
Lemos GT; Terrabuio DRB; Nunes NN; Song ATW; Oshiro ICV; D'Albuquerque LAC; Levin AS; Abdala E; Freire MP
Clin Transplant; 2024 Jan; 38(1):e15173. PubMed ID: 37877950
[TBL] [Abstract][Full Text] [Related]
2. Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?
Freire MP; Song ATW; Oshiro ICV; Andraus W; D'Albuquerque LAC; Abdala E
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115220. PubMed ID: 33045498
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.
Martin-Mateos R; Martínez-Arenas L; Carvalho-Gomes Á; Aceituno L; Cadahía V; Salcedo M; Arias A; Lorente S; Odriozola A; Zamora J; Blanes M; Len Ó; Benítez L; Campos-Varela I; González-Diéguez ML; Lázaro DR; Fortún J; Cuadrado A; Carrasco NM; Rodríguez-Perálvarez M; Álvarez-Navascues C; Fábrega E; Serrano T; Cuervas-Mons V; Rodríguez M; Castells L; Berenguer M; Graus J; Albillos A
J Hepatol; 2024 Jun; 80(6):904-912. PubMed ID: 38428641
[TBL] [Abstract][Full Text] [Related]
4. Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.
Ferstl PG; Filmann N; Heilgenthal EM; Schnitzbauer AA; Bechstein WO; Kempf VAJ; Villinger D; Schultze TG; Hogardt M; Stephan C; Mutlak H; Weiler N; Mücke MM; Trebicka J; Zeuzem S; Waidmann O; Welker MW
PLoS One; 2021; 16(1):e0245091. PubMed ID: 33481811
[TBL] [Abstract][Full Text] [Related]
5. Epidemic, risk factors of carbapenem-resistant
Liu N; Yang G; Dang Y; Liu X; Chen M; Dai F; Ding X; Li W; Li G; Lou J; Chen D; Yu Y
Front Cell Infect Microbiol; 2022; 12():976408. PubMed ID: 36275019
[TBL] [Abstract][Full Text] [Related]
6. Prediction models for carbapenem-resistant Enterobacterales carriage at liver transplantation: A multicenter retrospective study.
Freire MP; Rinaldi M; Terrabuio DRB; Furtado M; Pasquini Z; Bartoletti M; de Oliveira TA; Nunes NN; Lemos GT; Maccaro A; Siniscalchi A; Laici C; Cescon M; D Albuquerque LAC; Morelli MC; Song ATW; Abdala E; Viale P; Filho ADPC; Giannella M
Transpl Infect Dis; 2022 Dec; 24(6):e13920. PubMed ID: 35942941
[TBL] [Abstract][Full Text] [Related]
7. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes.
Freire MP; Soares Oshiro IC; Bonazzi PR; Guimarães T; Ramos Figueira ER; Bacchella T; Costa SF; Carneiro D'Albuquerque LA; Abdala E
Liver Transpl; 2013 Sep; 19(9):1011-9. PubMed ID: 23744748
[TBL] [Abstract][Full Text] [Related]
8. Infections due to multidrug-resistant organisms following heart transplantation: Epidemiology, microbiology, and outcomes.
Bhatt PJ; Ali M; Rana M; Patel G; Sullivan T; Murphy J; Pinney S; Anyanwu A; Huprikar S; Taimur S
Transpl Infect Dis; 2020 Feb; 22(1):e13215. PubMed ID: 31765045
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.
Barchiesi F; Montalti R; Castelli P; Nicolini D; Staffolani S; Mocchegiani F; Fiorentini A; Manso E; Vivarelli M
BMC Infect Dis; 2016 Oct; 16(1):538. PubMed ID: 27716164
[TBL] [Abstract][Full Text] [Related]
10. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Kalpoe JS; Sonnenberg E; Factor SH; del Rio Martin J; Schiano T; Patel G; Huprikar S
Liver Transpl; 2012 Apr; 18(4):468-74. PubMed ID: 22467548
[TBL] [Abstract][Full Text] [Related]
11. Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma.
Himmelsbach V; Knabe M; Ferstl PG; Peiffer KH; Stratmann JA; Wichelhaus TA; Hogardt M; Kempf VAJ; Zeuzem S; Waidmann O; Finkelmeier F; Ballo O
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1465-1472. PubMed ID: 34283288
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.
Verma A; Vimalesvaran S; Dhawan A
Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326850
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Pereira MR; Scully BF; Pouch SM; Uhlemann AC; Goudie S; Emond JE; Verna EC
Liver Transpl; 2015 Dec; 21(12):1511-9. PubMed ID: 26136397
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes.
Freire MP; Pierrotti LC; Oshiro IC; Bonazzi PR; Oliveira LM; Machado AS; Van Der Heijden IM; Rossi F; Costa SF; D'Albuquerque LA; Abdala E
Liver Transpl; 2016 May; 22(5):615-26. PubMed ID: 26684547
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors and Impact of Perioperative Prophylaxis on the Risk of Extended-spectrum β-Lactamase-producing Enterobacteriaceae-related Infection Among Carriers Following Liver Transplantation.
Logre E; Bert F; Khoy-Ear L; Janny S; Giabicani M; Grigoresco B; Toussaint A; Dondero F; Dokmak S; Roux O; Francoz C; Soubrane O; Durand F; Paugam-Burtz C; Weiss E
Transplantation; 2021 Feb; 105(2):338-345. PubMed ID: 32217945
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and outcomes of early infection in liver transplant recipients with acute-on-chronic liver failure.
Qian YB; Chen F; Hang HL; Shen C; Han LZ; Deng YX; Xia L; Zhang JJ; Xia Q
J Dig Dis; 2022 Nov; 23(11):642-650. PubMed ID: 36617995
[TBL] [Abstract][Full Text] [Related]
17. Carbapenems versus Cephalosporin or Piperacillin-Tazobactam as Perioperative Antibiotic Prophylaxis in Liver Transplant Recipients with Model for End-Stage Liver Disease Scores of ≥30: A Retrospective Study in a Chinese Population.
Zhang W; Chen Y; Zhang Y; Wang R; Wang W; Bai X; Liang T
Infect Drug Resist; 2022; 15():4487-4494. PubMed ID: 35983301
[TBL] [Abstract][Full Text] [Related]
18. Impact of Two Antibiotic Therapies on Clinical Outcome and Gut Microbiota Profile in Liver Transplant Paediatric Candidates Colonized by Carbapenem-Resistant
Cardile S; Del Chierico F; Candusso M; Reddel S; Bernaschi P; Pietrobattista A; Spada M; Torre G; Putignani L
Front Cell Infect Microbiol; 2021; 11():730904. PubMed ID: 34970503
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review.
Dolci G; Burastero GJ; Paglia F; Cervo A; Meschiari M; Guaraldi G; Chester J; Mussini C; Franceschini E
Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375108
[TBL] [Abstract][Full Text] [Related]
20. Bacterial and Fungal Infections After Liver Transplantation: Microbial Epidemiology, Risk Factors for Infection and Death with Infection.
Zhang W; Wang W; Kang M; Wu S; Liu Y; Liao Q; Xiao Y; Ma Y; Xie Y
Ann Transplant; 2020 May; 25():e921591. PubMed ID: 32424111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
